Syndrome of Inappropriate Antidiuretic Hormone Secretion Following Liver Transplantation.
Kosei Takagi(Okayama Shoka University), Toshiyoshi Fujiwara(Okayama University), Ryuichi Yoshida(Okayama University), Daisuke Nobuoka(Fukuyama City Hospital), Susumu Shinoura(Okayama University), Nobuyuki Watanabe(Okayama University), Takashi Kuise(Okayama Red Cross General Hospital), Takahito Yagi(Okayama University), Hiroyuki Araki(Okayama University), Tomokazu Fuji(Okayama University), Yuzo Umeda(Okayama University)
Cited by 6
Related Papers
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
|Molecular Cancer Therapeutics|2021|258
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
|OncoImmunology|2016|178
AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer
|JCI Insight|2018|148
The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer
|Journal of Experimental & Clinical Cancer Research|2018|111